Home » Pharmaceutical industry » Page 2

Tag

Pharmaceutical industry

News

North West Fund backs Evgen first close

Pharmaceutical business Evgen, a developer of a drug that may prevent and treat prostate cancer and other cancer, has closed a Series A investment round led by The North West Fund for Biomedical.

News

KalVista Pharmaceuticals launches on £8 million backing

Biotechnology company KalVista Pharmaceuticals has raised £8 million in a Series A financing round from life sciences venture investors Novo A/S and SV Life Sciences to develop a treatment for diabetes-related blindness.

News

Prosonix raises £11.4 million in Series B financing

Respiratory medicines business Prosonix has announced the completion of an £11.4 million Series B financing round led by Paris-based Ventech.

News

Shire buys diabetes drug manufacturer

Biopharmaceutical company Shire has acquired American business Advanced BioHealing as part of its move to build a new strategic business unit in regenerative medicine.

News

Acacia Pharma raises £6.2 million in Series A

Pharmaceutical company Acacia Pharma, a developer of drugs for cancer care support, has raised $10 million (£6.2 million) in a Series A investment round.

News

Viropro acquires biotech production facility

US-based biopharmaceutical company Viropro has acquired a Cambridge biotech facility in a deal worth $21 million (£13 million).

News

Azelis buys UK pharmaceuticals supplier

European speciality chemicals distributor, Azelis, is to acquire UK-based S&D Group for an undisclosed amount.

News

Masters Pharmaceuticals raises £2.65 million

A supplier of pharmaceuticals with offices in the UK, US and Singapore has raised £2.65 million from Albion Ventures.

News

Dublin drug company raises €18 million

Opsona Therapeutics, a drug development company based in Dublin, has completed a Series B round of funding.

News

Valeant to acquire Dow Pharmaceuticals

News

Alliance Boots acquires stake in Brazilian pharmaceutical wholesaler Athos Farma

Alliance Boots has purchased 25 per cent of Brazilian pharmaceutical wholesaler Athos Farma for an undisclosed amount. Read on for more deal headlines.

News

Matrix funds Focus Pharmaceuticals MBO

Private equity firm Matrix has financed the management buy-out (MBO) of Focus Pharmaceuticals, a Midlands-based company which brings pharmaceuticals to market. Matrix invested £3.2 million in a mix of debt and equity, and has acquired a minority stake in the business.

Recommended Content